Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1660.01%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 2.57Close
$ 1.31 - $ 5.75 52-Week Range
Ticker Information
Ticker
INOCompany Name
INOVIO PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINOVIO PHARMACEUTICALS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INO - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 3.03M | 1660.01% | $ 182.34K |
| 3/31/2025 | $ 3.11M | 1099.88% | $ 283.1K |
| 12/31/2024 | $ 3.13M | 1437.41% | $ 217.76K |
| 9/30/2024 | $ 2.53M | 1243.5% | $ 203.41K |
| 6/30/2024 | $ 2.8M | 472.47% | $ 591.86K |
| 3/31/2024 | $ 3.11M | 433.87% | $ 717.07K |
| 12/31/2023 | $ 3.5M | 421.09% | $ 832.01K |
| 9/30/2023 | $ 4.68M | 547.62% | $ 854.03K |
| 6/30/2023 | $ 5.01M | 52.04% | $ 9.62M |
| 3/31/2023 | $ 5.27M | 51.8% | $ 10.18M |
Key Performance Insights, Last 5 Years
- INOVIO PHARMACEUTICALS INC's latest trailing twelve months (TTM) DepAmor % stands at 259.63%.
- Over the past 5 years, INOVIO PHARMACEUTICALS INC's average DepAmor % has been 444.22%.
- The median DepAmor % for INOVIO PHARMACEUTICALS INC during this period was 263.1%
- INOVIO PHARMACEUTICALS INC reached its highest DepAmor % over the past 5 years at 1660.01%.
- The lowest DepAmor % recorded by INOVIO PHARMACEUTICALS INC in the same timeframe 50.35%
INOVIO PHARMACEUTICALS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for INOVIO PHARMACEUTICALS INC is calculated as follows: DepAmor [ $ 5.48M ] / Revenues [ $ 2.11M ]
(=) DepAmor % [ 259.63% ] INO - Depreciation and Amortization Margin, Last 5 years
50.35%
Minimum
Sep 30, 2022
1660.01%
Maximum
Jun 30, 2025
444.22%
Average
263.1%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |